ArticleDiscover oncology2022

LINC01089 blocks malignant progression of thyroid cancer by binding miR-27b-3p to enhance the FBLN5 protein level.

Yong-Qin Pan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.